Adult-Onset Still’s Disease

[1]  E. Feist,et al.  Mechanisms, biomarkers and targets for adult-onset Still’s disease , 2018, Nature Reviews Rheumatology.

[2]  D. Lipsker,et al.  Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult‐onset Still disease , 2018, Journal of the American Academy of Dermatology.

[3]  B. Fautrel,et al.  Complications of adult-onset Still’s disease and their management , 2018, Expert review of clinical immunology.

[4]  Jiajia Yang,et al.  Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis , 2018, Modern rheumatology.

[5]  J. Pouchot,et al.  Validation of the Fautrel classification criteria for adult-onset Still's disease. , 2018, Seminars in arthritis and rheumatism.

[6]  M. Tago,et al.  Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still’s Disease with Hemophagocytic Syndrome , 2017, The American journal of case reports.

[7]  Chengde Yang,et al.  A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease , 2017, Scientific Reports.

[8]  E. Feist,et al.  Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review). , 2017, Seminars in arthritis and rheumatism.

[9]  L. Punzi,et al.  Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study , 2017, Front. Pharmacol..

[10]  F. Spertini,et al.  Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease , 2017, Annals of the rheumatic diseases.

[11]  J. Chertoff,et al.  Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease , 2017, Pulmonary circulation.

[12]  B. Fautrel,et al.  New Markers for Adult-Onset Still's Disease. , 2017, Joint, bone, spine : revue du rhumatisme.

[13]  M. McDermott,et al.  Lessons from characterization and treatment of the autoinflammatory syndromes , 2017, Current opinion in rheumatology.

[14]  M. McDermott,et al.  The burgeoning field of innate immune‐mediated disease and autoinflammation , 2017, The Journal of pathology.

[15]  M. Khanfir,et al.  Successful treatment of refractory adult onset Still's disease with rituximab. , 2016, Reumatismo.

[16]  H. Kato,et al.  Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra , 2016, Case reports in rheumatology.

[17]  K. Fushimi,et al.  Epidemiological study of adult-onset Still’s disease using a Japanese administrative database , 2016, Rheumatology International.

[18]  C. Suh,et al.  TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still’s Disease and Their Association with Disease Activity and Clinical Manifestations , 2016, International journal of molecular sciences.

[19]  L. Guilleminault,et al.  Pulmonary arterial hypertension in adult onset Still’s disease: a case report of a severe complication , 2016, BMC Pulmonary Medicine.

[20]  M. Mehta,et al.  An Atypical Presentation of Adult-Onset Still's Disease Complicated by Pulmonary Hypertension and Macrophage Activation Syndrome Treated with Immunosuppression: A Case-based Review of the Literature , 2016, Pulmonary circulation.

[21]  S. Hofmann,et al.  Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release. , 2015, Clinical immunology.

[22]  E. Zeggini,et al.  HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis , 2015, Proceedings of the National Academy of Sciences.

[23]  I. Touitou,et al.  Autoinflammation: Management of hereditary recurrent fevers—SHARE experience , 2015, Nature Reviews Rheumatology.

[24]  E. Zeggini,et al.  HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis , 2015, Pediatric Rheumatology.

[25]  C. Suh,et al.  Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease , 2015, Arthritis Research & Therapy.

[26]  M. González-Gay,et al.  Efficacy of Anakinra in Refractory Adult-Onset Still's Disease , 2015, Medicine.

[27]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[28]  Chi-Chen Lin,et al.  The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease , 2015, BMC Musculoskeletal Disorders.

[29]  T. Takeuchi,et al.  The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study , 2015, Modern rheumatology.

[30]  F. Al-Mohanna,et al.  Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis , 2015, Arthritis & rheumatology.

[31]  M. Shimodaira,et al.  Adult-onset Still’s disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report , 2014, BMC Research Notes.

[32]  C. Suh,et al.  Serum S100A12 May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease , 2014, The Journal of Rheumatology.

[33]  Dongsheng Hong,et al.  Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety , 2014, Drug design, development and therapy.

[34]  F. Martinon,et al.  Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart , 2014, Immunologic Research.

[35]  Y. Shoenfeld,et al.  sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia , 2014, Immunologic Research.

[36]  I. Touitou,et al.  Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. , 2014, Autoimmunity reviews.

[37]  G. Hejblum,et al.  Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome , 2014, Arthritis & rheumatology.

[38]  P. Sève,et al.  Adult-onset Still's disease. , 2014, Autoimmunity reviews.

[39]  C. Serhan.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[40]  R. Priori,et al.  Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still’s Disease and Sepsis , 2014, The Journal of Rheumatology.

[41]  H. Yamanaka,et al.  Clinical Manifestations of Adult‐Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin‐18 , 2014, Arthritis care & research.

[42]  M. Humbert,et al.  Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension: A Complex Interplay , 2014, Circulation.

[43]  R. Namas,et al.  An Unusual Case of Adult-Onset Still's Disease with Hemophagocytic Syndrome, Necrotic Leukoencephalopathy and Disseminated Intravascular Coagulation , 2014, Case reports in rheumatology.

[44]  D. Maucort-Boulch,et al.  Adult-Onset Still Disease , 2014, Medicine.

[45]  S. Bombardieri,et al.  Successful treatment of refractory adult-onset still disease with canakinumab: a case report. , 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[46]  J. Jun,et al.  Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease , 2014, Scandinavian journal of rheumatology.

[47]  R. Zolty,et al.  A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult‐onset Still's disease: targeting IL‐6 , 2014, International journal of rheumatic diseases.

[48]  J. Ablin,et al.  Tocilizumab in Adult-onset Still’s Disease: the Israeli Experience , 2014, The Journal of Rheumatology.

[49]  C. Salvarani,et al.  Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations. , 2014, Joint, bone, spine : revue du rhumatisme.

[50]  B. Mehta,et al.  Life-threatening complications of adult-onset Still’s disease , 2014, Clinical Rheumatology.

[51]  S. Amselem,et al.  How should we approach classification of autoinflammatory diseases? , 2013, Nature Reviews Rheumatology.

[52]  L. Spahr,et al.  Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease , 2013, Case reports in hepatology.

[53]  Z. Amoura,et al.  Anakinra in Adult‐Onset Still's Disease: Long‐Term Treatment in Patients Resistant to Conventional Therapy , 2013, Arthritis care & research.

[54]  C. Ramos-Remus,et al.  Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease. , 2013, Clinical and experimental rheumatology.

[55]  I. Touitou.  Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature , 2013, Journal of Medical Genetics.

[56]  T. Ishida,et al.  A case of adult-onset Still’s disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema , 2013, Modern rheumatology.

[57]  S. Agrawal,et al.  Pulmonary arterial hypertension complicating adult-onset Still’s disease , 2013, Clinical Rheumatology.

[58]  P. Efthimiou,et al.  The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease. , 2012, Seminars in arthritis and rheumatism.

[59]  E. Schiopu,et al.  Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra , 2012, Case reports in rheumatology.

[60]  C. Suh,et al.  Serum S100A8/A9, But Not Follistatin-like Protein 1 and Interleukin 18, May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease , 2012, The Journal of Rheumatology.

[61]  J. Cush,et al.  IL-1 Trap rilonacept in refractory adult onset Still's disease , 2012, Annals of the rheumatic diseases.

[62]  G. Panayi,et al.  Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns. , 2012, Rheumatology.

[63]  W. Zucchini,et al.  The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. , 2011, Seminars in arthritis and rheumatism.

[64]  R. Tehrani,et al.  Refractory adult-onset still disease successfully treated with abatacept. , 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[65]  C. Macaubas,et al.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions , 2011, Nature Reviews Rheumatology.

[66]  I. McInnes,et al.  Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. , 2011, Rheumatology.

[67]  C. Dejaco,et al.  Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature , 2011, Rheumatology International.

[68]  J. Sibilia,et al.  Tocilizumab in refractory adult Still's disease , 2011, Arthritis care & research.

[69]  M. Schiller,et al.  Clinical Manifestations but not Cytokine Profiles Differentiate Adult-onset Still’s Disease and Sepsis , 2010, The Journal of Rheumatology.

[70]  H. Endo,et al.  Exacerbation of adult‐onset Still’s disease, possibly related to elevation of serum tumor necrosis factor‐alpha after etanercept administration , 2010, International journal of rheumatic diseases.

[71]  S. Inokuma,et al.  Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases , 2010, The Journal of Rheumatology.

[72]  L. Quartuccio,et al.  Efficacy of abatacept in a refractory case of adult-onset Still's disease. , 2010, Clinical and experimental rheumatology.

[73]  Andreas Krause,et al.  IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still’s disease , 2010, Annals of the rheumatic diseases.

[74]  J. Pouchot,et al.  Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor? , 2009, Arthritis and rheumatism.

[75]  M. Govoni,et al.  Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation , 2009, Rheumatology International.

[76]  C. Cohn,et al.  Thrombotic thrombocytopenic purpura and adult onset Still's disease. , 2009, The American journal of the medical sciences.

[77]  P. Conigliaro,et al.  Lymph node IL-18 expression in adult-onset Still’s disease , 2009, Annals of the rheumatic diseases.

[78]  M. Iwamoto,et al.  Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab , 2009, Clinical Rheumatology.

[79]  D. Foell,et al.  S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. , 2008, Arthritis & Rheumatism.

[80]  B. Fautrel.  Adult-onset Still disease. , 2008, Best practice & research. Clinical rheumatology.

[81]  O. Lambotte,et al.  Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. , 2008, Arthritis and rheumatism.

[82]  Shun-le Chen,et al.  The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease. , 2008, Clinical biochemistry.

[83]  L. Kanz,et al.  Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. , 2007, Seminars in arthritis and rheumatism.

[84]  J. Sibilia,et al.  Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France , 2007, Annals of the rheumatic diseases.

[85]  M. McDermott,et al.  The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self , 2007, Seminars in Immunopathology.

[86]  Y. Shoenfeld,et al.  Ferritin in autoimmune diseases. , 2007, Autoimmunity reviews.

[87]  M. Heldmann,et al.  Pulmonary hypertension in a patient with adult-onset stills disease , 2007, Clinical Rheumatology.

[88]  P. Efthimiou,et al.  Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? , 2007, Nature Clinical Practice Rheumatology.

[89]  A. Malaviya,et al.  Ten years of clinical experience with adult onset Still’s disease: is the outcome improving? , 2007, Clinical Rheumatology.

[90]  G. Kalliolias,et al.  Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial , 2007, Annals of the rheumatic diseases.

[91]  A. Ramanan,et al.  The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[92]  Dennis McGonagle,et al.  A Proposed Classification of the Immunological Diseases , 2006, PLoS medicine.

[93]  N. Kamatani,et al.  Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's disease. , 2006, Rheumatology.

[94]  C. Chou,et al.  Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[95]  R. Caporali,et al.  Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. , 2006, Clinical and experimental rheumatology.

[96]  J. Alcocer-Varela,et al.  Adult-Onset Still Disease as the Cause of Fever of Unknown Origin , 2005, Medicine.

[97]  T. Hsieh,et al.  Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. , 2005, Arthritis and rheumatism.

[98]  C. Dinarello,et al.  Rapid responses to anakinra in patients with refractory adult-onset Still's disease. , 2005, Arthritis and rheumatism.

[99]  D. Foell,et al.  Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.

[100]  T. Hsieh,et al.  Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. , 2004, The Journal of rheumatology.

[101]  B. Bresnihan,et al.  Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis , 2004, Annals of the rheumatic diseases.

[102]  J. Cañete,et al.  Palindromic rheumatism and other relapsing arthritis. , 2004, Best practice & research. Clinical rheumatology.

[103]  I. Ben Ghorbel,et al.  [Amyloidosis in adult onset Still's disease]. , 2004, La Revue de medecine interne.

[104]  M. Audran,et al.  Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. , 2004, Joint, bone, spine : revue du rhumatisme.

[105]  X. Mariette,et al.  Tumour necrosis factor α blocking agents in refractory adult Still’s disease: an observational study of 20 cases , 2004 .

[106]  L. Goodnough,et al.  Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. , 2004, Blood.

[107]  D. Foell,et al.  Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. , 2004, Arthritis and rheumatism.

[108]  C. Suh,et al.  Serum cytokine profiles in patients with adult onset Still's disease. , 2003, The Journal of rheumatology.

[109]  J. Piette,et al.  High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. , 2003, The Journal of rheumatology.

[110]  N. Kamatani,et al.  Association between adult-onset Still's disease and interleukin-18 gene polymorphisms , 2002, Genes and Immunity.

[111]  B. Lämmle,et al.  Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. , 2002, Blood.

[112]  M. Weinblatt,et al.  Etanercept in the treatment of adult patients with Still's disease. , 2002, Arthritis and rheumatism.

[113]  J. Piette,et al.  Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease , 2002, Medicine.

[114]  J. Piette,et al.  Drug-induced hemophagocytosis. , 2002, The American journal of medicine.

[115]  C. Antoni,et al.  Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences , 2001, Annals of the rheumatic diseases.

[116]  N. Kamatani,et al.  Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. , 2001, Arthritis and rheumatism.

[117]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[118]  D. Nicolae,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[119]  R. Caporali,et al.  Infliximab in the treatment of adult Still's disease refractory to conventional therapy. , 2001, Clinical and experimental rheumatology.

[120]  河島 昌典.  Levels of Interleukin-18 and Its Binding Inhibitors in the Blood Circulation of Patients with Adult-Onset Still's Disease , 2001 .

[121]  T. Tanimoto,et al.  Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. , 2001, Arthritis and rheumatism.

[122]  J. Piette,et al.  Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. , 2001, The Journal of rheumatology.

[123]  S. Bae,et al.  Secondary Renal Amyloidosis in Adult Onset Still’s Disease: Case report and Review of the Literature , 2000, The Korean journal of internal medicine.

[124]  F. Ohsuzu,et al.  Calcinosis cutis and intestinal pseudoobstruction in a patient with adult onset Still's disease associated with recurrent relapses of disordered coagulopathy. , 1999, Internal medicine.

[125]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[126]  O. Meyer,et al.  Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. , 1999, The Journal of rheumatology.

[127]  J. Piette,et al.  Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease , 1998, Annals of the rheumatic diseases.

[128]  H. Mittermayer,et al.  Hyperferritinemia as a marker of Still's disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[129]  E. Batlle-Gualda,et al.  Vascular renal AA amyloidosis in adult Still's disease. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[130]  M. Weisman,et al.  Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature. , 1997, The Journal of rheumatology.

[131]  T. Mimori,et al.  Methotrexate treatment in patients with adult onset Still’s disease—retrospective study of 13 Japanese cases , 1997, Annals of the rheumatic diseases.

[132]  H. Moutsopoulos,et al.  Thrombotic thrombocytopenic purpura in adult Still's disease. , 1996, The Journal of rheumatology.

[133]  M. Audran,et al.  Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. , 1995, Revue du rhumatisme.

[134]  M. Audran,et al.  Adult Still's disease. Part II. Management, outcome, and prognostic factors. , 1995, Revue du rhumatisme.

[135]  A. Prost,et al.  Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. , 1995, Annals of the rheumatic diseases.

[136]  R. Means,et al.  Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. , 1995, The American journal of medicine.

[137]  T. Mimori,et al.  [A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation]. , 1995, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[138]  J. Fries,et al.  A controlled study of the long-term prognosis of adult Still's disease. , 1995, The American journal of medicine.

[139]  J. V. D. van der Meer,et al.  Hyperimmunoglobulinemia D and Periodic Fever Syndrome: The Clinical Spectrum in a Series of 50 Patients , 1994, Medicine.

[140]  M. Kahn,et al.  Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. , 1994, The Journal of rheumatology.

[141]  J. Maldonado-Cocco,et al.  Adult Still's disease and inflammatory myositis. , 1993, Clinical and experimental rheumatology.

[142]  G. Hughes,et al.  Low dose methotrexate treatment in adult Still's disease. , 1992, The Journal of rheumatology.

[143]  M. Akizuki,et al.  Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.

[144]  J. Esdaile,et al.  Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients , 1991, Medicine.

[145]  M. Akizuki,et al.  Adult Still's disease: a multicenter survey of Japanese patients. , 1990, The Journal of rheumatology.

[146]  C. Lyberatos.  Two more cases of Still's disease and Kikuchi's. , 1990, Journal of Rheumatology.

[147]  Y. Asakawa,et al.  [A case of adult Still's disease with pulmonary hypertension]. , 1990, Ryumachi. [Rheumatism].

[148]  R. Artymyshyn,et al.  Coexistence of adult onset Still's disease and polymyositis with rhabdomyolysis successfully treated with methotrexate and corticosteroids. , 1989, The Journal of rheumatology.

[149]  E. Martı́n-Mola,et al.  Serum ferritin can be useful for diagnosis in adult onset Still's disease. , 1989, The Journal of rheumatology.

[150]  A. Ohta,et al.  Adult Still's disease: review of 228 cases from the literature. , 1987, The Journal of rheumatology.

[151]  J. Ferreirós,et al.  Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. , 1987, Seminars in arthritis and rheumatism.

[152]  S. Eto,et al.  INCREASED SERUM FERRITIN LEVELS IN ADULT STILL'S DISEASE , 1987, The Lancet.

[153]  L. van de Putte,et al.  Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. , 1986, The Quarterly journal of medicine.

[154]  R. Terkeltaub,et al.  HLA-Bw35 and prognosis in adult Still's disease. , 1981, Arthritis and rheumatism.

[155]  Harrington Tm,et al.  Amyloidosis in adult onset Still's disease. , 1981, The Journal of rheumatology.

[156]  T. Medsger,et al.  Carpal arthritis with ankylosis in late onset Still's disease. , 1976, Arthritis and rheumatism.

[157]  E. Bywaters.  Still's disease in the adult. , 1971, Annals of the rheumatic diseases.

[158]  E. Lee,et al.  Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases. , 2016, Clinical and experimental rheumatology.

[159]  M. Haranaka,et al.  Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease. , 2014, Internal medicine.

[160]  R. Giacomelli,et al.  Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series , 2013, Clinical Rheumatology.

[161]  M. Govoni,et al.  Adult-onset Still’s disease , 2009, Rheumatology International.

[162]  M. E. Siqueira,et al.  Adult-onset Still's disease and pulmonary arterial hypertension , 2009 .

[163]  G. Cook,et al.  Primer: inflammasomes and interleukin 1β in inflammatory disorders , 2008, Nature Clinical Practice Rheumatology.

[164]  X. Mariette,et al.  Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. , 2005, Annals of the rheumatic diseases.

[165]  Jung-Han Kim,et al.  Stereotactic Core-Needle Biopsy of Non-Mass Calcifications: Outcome and Accuracy at Long-Term Follow-Up , 2003, Korean journal of radiology.

[166]  S. Bae,et al.  Copyright � The Korean Academy of Medical Sciences Adult-onset Still's Disease with Disseminated Intravascular Coagulation , 2002 .

[167]  A. Ohta.  [Adult Still's disease]. , 2000, Ryoikibetsu shokogun shirizu.

[168]  A. Tamakoshi,et al.  Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. , 1997, Journal of epidemiology.

[169]  I. Giannakakis,et al.  Ferritin levels and response to treatment in patients with Adult Still's disease. , 1996, The Journal of rheumatology.

[170]  T. Kawanami,et al.  Systemic amyloidosis in a patient with adult onset Still's disease. , 1993, Internal medicine.

[171]  L. van de Putte,et al.  Adult-onset Still's disease. , 1991, Baillière's Clinical Rheumatology.

[172]  J. Cabane,et al.  [Pseudo-Still disease and neoplasm. 2 cases]. , 1988, La Revue de medecine interne.

[173]  J. Cabane,et al.  Pseudo-maladie de Still et néoplasie Deux observations , 1988 .

[174]  S. Benito Urbina,et al.  [Still's disease in the adult]. , 1983, Revista clinica espanola.